Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2020

01-12-2020 | Acarbose | Research article

Gene set enrichment analysis of α-amylase and α-glucosidase inhibitors of Cassia glauca

Authors: Shama G Ternikar, MB Patil, Ismail Pasha, Pukar Khanal

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Login to get access

Abstract

Background

The present study aimed to evaluate in vitro α-amylase and α-glucosidase inhibitory activity of various extracts of Cassia glauca, predict the binding affinity of multiple phytoconstituents with both enzymes via in silico molecular docking and identify the probably modulated pathways by the lead hit.

Methods

Different extracts of Cassia glauca i.e. acetone, ethanol, and aqueous extracts were evaluated for α-amylase and α-glucosidase inhibitory activity using in vitro method in which starch and 4-Nitrophenyl β-D-glucopyranoside were used as substrate respectively. Similarly, the docking study was performed using autodock4 to predict the binding affinity of phytoconstituents with α-amylase and α-glucosidase. After docking, ten different poses were obtained for the ligand molecule. Among them, the pose of ligand molecule with the lowest binding energy was visualized in Discovery Studio 2019.

Results and conclusion

Among the multiple extracts, the aqueous extract showed the highest α-amylase (IC50:652.10 ± 20.09) and α-glucosidase (IC50:482.46 ± 8.70) inhibitory activity. Similarly, cassiaoccidentalin B was predicted to have the highest binding affinity with both enzymes. The potency of aqueous extract to inhibit α-amylase and α-glucosidase could be due to multiple water-soluble compounds like saponins, flavonoids, and glycosides.
Literature
1.
go back to reference American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–9.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–9.CrossRef
2.
go back to reference Campbell RK. Pharmacotherapy of diabetes: past, present, and future: preface diabetes. Spectr. 2014;27:79–80. Campbell RK. Pharmacotherapy of diabetes: past, present, and future: preface diabetes. Spectr. 2014;27:79–80.
3.
go back to reference Lebovitz HE. Alpha-glucosidase inhibitors. Endocrinol Metab Clin N Am. 1997;26:539–51.CrossRef Lebovitz HE. Alpha-glucosidase inhibitors. Endocrinol Metab Clin N Am. 1997;26:539–51.CrossRef
4.
go back to reference Kasole R, Martin HD, Kimiywe J. Traditional medicine and its role in the Management of Diabetes Mellitus: “patients’ and herbalists’ perspectives”. Evid Based Complement Alternat Med. 2019;2019:2835691.CrossRef Kasole R, Martin HD, Kimiywe J. Traditional medicine and its role in the Management of Diabetes Mellitus: “patients’ and herbalists’ perspectives”. Evid Based Complement Alternat Med. 2019;2019:2835691.CrossRef
5.
go back to reference Mawlieh BS, Shastry CS, Chand S. Evaluation of anti-diabetic activity of two marketed herbal formulations. Research Journal of Pharmacy and Technology. 2020;13(2):664–8.CrossRef Mawlieh BS, Shastry CS, Chand S. Evaluation of anti-diabetic activity of two marketed herbal formulations. Research Journal of Pharmacy and Technology. 2020;13(2):664–8.CrossRef
6.
go back to reference Wanjari MM, Mishra S, Dey YN, Sharma D, Gaidhani SN, Jadhav AD. Antidiabetic activity of Chandraprabha vati - a classical Ayurvedic formulation. J Ayurveda Integr Med. 2016;7(3):144–50.CrossRef Wanjari MM, Mishra S, Dey YN, Sharma D, Gaidhani SN, Jadhav AD. Antidiabetic activity of Chandraprabha vati - a classical Ayurvedic formulation. J Ayurveda Integr Med. 2016;7(3):144–50.CrossRef
20.
go back to reference Duyu T, Khatib NA, Khanal P, Patil BM, Hullatti KK. Network pharmacology-based prediction and experimental validation of Mimosa pudica for Alzheimer's disease. J Phytopharmacol. 2020;9(1):46–53.CrossRef Duyu T, Khatib NA, Khanal P, Patil BM, Hullatti KK. Network pharmacology-based prediction and experimental validation of Mimosa pudica for Alzheimer's disease. J Phytopharmacol. 2020;9(1):46–53.CrossRef
23.
go back to reference Khanal P, Patil BM, Mandar BK, Dey YN, Duyu T. Network pharmacology-based assessment to elucidate the molecular mechanism of anti-diabetic action of Tinospora cordifolia. Clin Phytosci. 2019;5(1):35.CrossRef Khanal P, Patil BM, Mandar BK, Dey YN, Duyu T. Network pharmacology-based assessment to elucidate the molecular mechanism of anti-diabetic action of Tinospora cordifolia. Clin Phytosci. 2019;5(1):35.CrossRef
Metadata
Title
Gene set enrichment analysis of α-amylase and α-glucosidase inhibitors of Cassia glauca
Authors
Shama G Ternikar
MB Patil
Ismail Pasha
Pukar Khanal
Publication date
01-12-2020
Publisher
Springer International Publishing
Keywords
Acarbose
Diabetes
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00538-9

Other articles of this Issue 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.